11-18934292-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001393578.1(MRGPRX1):āc.493T>Cā(p.Phe165Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001393578.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRGPRX1 | NM_001393578.1 | c.493T>C | p.Phe165Leu | missense_variant | 2/2 | ENST00000526914.2 | NP_001380507.1 | |
MRGPRX1 | NM_147199.4 | c.493T>C | p.Phe165Leu | missense_variant | 1/1 | NP_671732.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRGPRX1 | ENST00000526914.2 | c.493T>C | p.Phe165Leu | missense_variant | 2/2 | 3 | NM_001393578.1 | ENSP00000499076.2 | ||
MRGPRX1 | ENST00000302797.4 | c.493T>C | p.Phe165Leu | missense_variant | 1/1 | 6 | ENSP00000305766.3 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250802Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135596
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459444Hom.: 0 Cov.: 36 AF XY: 0.00000275 AC XY: 2AN XY: 726040
GnomAD4 genome Cov.: 35
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.493T>C (p.F165L) alteration is located in exon 1 (coding exon 1) of the MRGPRX1 gene. This alteration results from a T to C substitution at nucleotide position 493, causing the phenylalanine (F) at amino acid position 165 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at